AEAbigail L. Emtage

Abigail L. Emtage

*This is an algorithmically generated author record based on publicly available information.

Abigail L. Emtage has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Development and evaluation of pilot simulated patient centre: Learning from the experience

    by Bee Yean Low, Emily Farrow, Abigail Emtage

    Objectives: To compare the performance of paid actor-simulated patients: 1) before and after a simulated patient training programme aiming for programme enhancement; 2) to postgraduate/staff-simulated patients. Methods: Fifty-six student participants watched a series of video recordings of student pharmacist-paid actor-simulated patients role-playing and blindly assessed the performance of paid actor-simulated patients pre- and post-training using the Maastricht Assessment of Simulated Patients (MaSP). Seventy-three student participants compared the paid actor-simulated patients' performance to postgraduate/staff-simulated patients. Data collected were analysed using paired t-tests and independent t-tests, respectively. Results: There was a statistically significant improvement in the collated MaSP scores for paid actor-simulated patients' performance post-training in the authenticity of role-playing (mean score +/- standard deviation (SD): 2.61 +/- 0.30 (Pre-training); 2.70 +/- 0.31 (Post training), p < 0.05) but not the quality of feedback. Similarly, paid actor-simulated patients performed better (in the authenticity of role-playing but not the quality of feedback) when compared to postgraduate/staff-simulated patients. Conclusions: Paid actor-simulated patients require improvement in providing quality feedback to students to enhance students' learning.


  • Open Access

    Ligand discrimination during virtual screening of the CB1 cannabinoid receptor crystal structures following cross-docking and microsecond molecular dynamics simulations

    by Jason S. E. Loo, Abigail L. Emtage, Lahari Murali, Sze Siew Lee, Alvina L. W. Kueh, Stephen P. H. Alexander

    The therapeutic potential of the CB1 cannabinoid receptor remains underexploited with only a few synthetic ligands on the market. The crystal structures of both the inactive and active-state CB1 receptor have recently been solved, allowing for unprecedented opportunities in structure-based drug discovery applications such as virtual screening. In this study, we have investigated the virtual screening performance of the active and inactive-state CB1 crystal structures and their ability to discriminate between agonist and inverse agonist/antagonist ligands. The ligands of inactive and active-state CB1 receptor crystal structures were then swapped via cross-docking and the resulting structures were subjected to microsecond molecular dynamics (MD) simulations, followed by virtual screening of the MD-extracted structures. The original crystal structures were found to be biased towards ligands matching their activation state during virtual screening. MD simulations of the cross-docked CB1 structures resulted in a minor shift of receptor conformation towards the inactive state for the active-state CB1 structure complexed with the inverse agonist taranabant. Effects on virtual screening were more pronounced, as MD simulations of the cross-docked receptor–ligand complexes reversed the ligand bias in virtual screening observed with the original crystal structures. The simulations also produced receptor conformations that outperformed the crystal structures in virtual screening and in predicting the binding pose of the cognate ligand. The findings of this study highlight the potential of cross-docking and MD simulations to reverse the ligand bias of crystal structures, which may be useful when the crystal structure of only one activation state is available.


  • Evaluating the performance of MM/PBSA for binding affinity prediction using class A GPCR crystal structures

    by Mei Qian Yau, Abigail L. Emtage, Nathaniel J. Y. Chan, Stephen W. Doughty, Jason S. E. Loo

    The recent expansion of GPCR crystal structures provides the opportunity to assess the performance of structure-based drug design methods for the GPCR superfamily. Molecular Mechanics/Poisson-Boltzmann Surface Area (MM/PBSA)-based methods are commonly used for binding affinity prediction, as they provide an intermediate compromise of speed and accuracy between the empirical scoring functions used in docking and more robust free energy perturbation methods. In this study, we systematically assessed the performance of MM/PBSA in predicting experimental binding free energies using twenty Class A GPCR crystal structures and 934 known ligands. Correlations between predicted and experimental binding free energies varied significantly between individual targets, ranging from r = − 0.334 in the inactive-state CB1 cannabinoid receptor to r = 0.781 in the active-state CB1 cannabinoid receptor, while average correlation across all twenty targets was relatively poor (r = 0.183). MM/PBSA provided better predictions of binding free energies compared to docking scores in eight out of the twenty GPCR targets while performing worse for four targets. MM/PBSA binding affinity predictions calculated using a single, energy minimized structure provided comparable predictions to sampling from molecular dynamics simulations and may be more efficient when computational cost becomes restrictive. Additionally, we observed that restricting MM/PBSA calculations to ligands with a high degree of structural similarity to the crystal structure ligands improved performance in several cases. In conclusion, while MM/PBSA remains a valuable tool for GPCR structure-based drug design, its performance in predicting the binding free energies of GPCR ligands remains highly system-specific as demonstrated in a subset of twenty Class A GPCRs, and validation of MM/PBSA-based methods for each individual case is recommended before prospective use.


  • Open Access

    Evaluating the Performance of MM/PBSA for Binding Affinity Prediction Using G Protein-Coupled Receptor Crystal Structures

    by Mei Qian Yau, Abigail Emtage, Jason S. Loo

    Background The diverse G protein-coupled receptors (GPCRs) are major drug targets. The recently solved GPCR crystal structures offer opportunities to utilize various structure-based computational methods for drug design. Among these methods is Molecular Mechanics/Poisson-Boltzmann Surface Area (MM/PBSA). As an end-state method, MM/PBSA provides a compromise of speed and accuracy between docking and free energy perturbation methods in predicting binding free energies. In this study, we evaluated the performance of MM/PBSA, which has been shown to be system-specific, using GPCR crystal structures. Methods Crystal structures of 15 Class A GPCRs were obtained from the Protein Data Bank. For each structure, a set of ligands with similar scaffold to the co-crystallized ligand and pKi values ranging from 5-10 were obtained from the ChEMBL database. The ligands were docked into the structures using Schrödinger’s Induced Fit Docking protocol. Molecular dynamics simulations were then performed using GROMACS with the AMBER ff99SB*-ILDN force field. MM/PBSA calculations were subsequently performed using g_mmpbsa, with the solute dielectric constants varied between 1, 2 and 4 to obtain the best correlation. Results The Pearson (rp) and Spearman (rs) correlations obtained between the MM/PBSA-predicted and experimental binding free energies ranged from -0.23-0.78 and -0.32-0.79 respectively. With the exception of a single target (5XRA: rp=0.78, rs=0.79), correlations produced by MM/PBSA were generally poor. MM/PBSA improved the correlations in only 7 out of 15 targets when compared to docking scores, which provided correlations in the range of rp -0.43-0.43 and rs -0.44-0.50. Conclusion The performance of MM/PBSA in predicting binding free energies using GPCR crystal structures remains relatively weak overall, but may provide good predictions for certain targets and offer marginal improvements over docking scores for some others. When using MM/PBSA to predict binding free energies of GPCR ligands, validation of the method for each target is therefore recommended.

  • Open Access

    The fitness burden imposed by synthesising quorum sensing signals

    by A. Ruparell, J. F. Dubern, C. A. Ortori, F. Harrison, N. M. Halliday, A. Emtage, M. M. Ashawesh, C. A. Laughton, S. P. Diggle, P. Williams, et al.

    It is now well established that bacterial populations utilize cell-to-cell signaling (quorum-sensing, QS) to control the production of public goods and other co-operative behaviours. Evolutionary theory predicts that both the cost of signal production and the response to signals should incur fitness costs for producing cells. Although costs imposed by the downstream consequences of QS have been shown, the cost of QS signal molecule (QSSM) production and its impact on fitness has not been examined. We measured the fitness cost to cells of synthesising QSSMs by quantifying metabolite levels in the presence of QSSM synthases. We found that: (i) bacteria making certain QSSMs have a growth defect that exerts an evolutionary cost, (ii) production of QSSMs negatively correlates with intracellular concentrations of QSSM precursors, (iii) the production of heterologous QSSMs negatively impacts the production of a native QSSM that shares common substrates, and (iv) supplementation with exogenously added metabolites partially rescued growth defects imposed by QSSM synthesis. These data identify the sources of the fitness costs incurred by QSSM producer cells, and indicate that there may be metabolic trade-offs associated with QS signaling that could exert selection on how signaling evolves.


  • GPCRs through the keyhole: the role of protein flexibility in ligand binding to β-adrenoceptors

    by Abigail L. Emtage, Shailesh N. Mistry, Peter M. Fischer, Barrie Kellam, Charles A. Laughton

    G protein-coupled receptors (GPCRs) are proteins of pharmaceutical importance, with over 30% of all drugs in clinical use targeting them. Increasing numbers of X-ray crystal (XRC) structures of GPCRs offer a wealth of data relating to ligand binding. For the β-adrenoceptors (β-ARs), XRC structures are available for human β2- and turkey β1-subtypes, in complexes with a range of ligands. While these structures provide insight into the origins of ligand structure-activity relationships (SARs), questions remain. The ligands in all published complexed XRC structures lack extensive substitution, with no obvious way the ligand-binding site can accommodate β1-AR-selective antagonists with extended side-chains para- to the common aryloxypropanolamine pharmacophore. Using standard computational docking tools with such ligands generally returns poses that fail to explain known SARs. Application of our Active Site Pressurisation modelling method to β-AR XRC structures and homology models, however, reveals a dynamic area in the ligand-binding pocket that, through minor changes in amino acid side chain orientations, opens a fissure between transmembrane helices H4 and H5, exposing intra-membrane space. This fissure, which we term the “keyhole”, is ideally located to accommodate extended moieties present in many high-affinity β1-AR-selective ligands, allowing the rest of the ligand structure to adopt a canonical pose in the orthosteric binding site. We propose the keyhole may be a feature of both β1- and β2-ARs, but that subtle structural differences exist between the two, contributing to subtype-selectivity. This has consequences for the rational design of future generations of subtype-selective ligands for these therapeutically important targets.


  • Open Access

    The fitness burden imposed by synthesising quorum sensing signals

    by Avika Ruparell, Jean Frederic Dubern, Ca. Ortori, Freya Harrison, Nigel M Halliday, Abigail Emtage, Mahmoud Ashawesh, Ca. Laughton, Steve Diggle, Paul Williams, et al.

    Summary: It is now well established that bacterial populations utilize cell-to-cell signaling (quorum-sensing, QS) to control the production of public goods and other co-operative behaviours. Evolutionary theory predicts that both the cost of signal production and the response to signals should incur fitness costs for producing cells. Although costs imposed by the downstream consequences of QS have been shown, it has not been demonstrated that the production of QS signal molecules (QSSMs) results in a decrease in fitness. We measured the fitness cost to cells of synthesising QSSMs by quantifying metabolite levels in the presence of QSSM synthases. We found that: (i) bacteria making QSSMs have a growth defect that exerts an evolutionary cost, (ii) production of QSSMs correlates with reduced intracellular concentrations of QSSM precursors, (iii) the production of heterologous QSSMs negatively impacts the production of a native QSSM that shares common substrates, and (iv) supplementation with exogenously added metabolites partially rescued growth defects imposed by QSSM synthesis. These data provide the first direct experimental evidence that the production of QS signals carries fitness costs to producer cells. Originality-Significance Statement: Bacterial cells within populations communicate with each other to control social behaviors by producing diffusible quorum sensing (QS) signal molecules. Evolutionary theory predicts that both the cost of signal production and the response to signals should incur fitness costs for producing cells. Here we provide the first empirical evidence that the production of QS signals incurs fitness costs to producing cells. Since QS plays a major role in bacterial pathogenicity, this finding will underpin novel antimicrobial strategies that are urgently needed to replace currently available antimicrobials that are becoming obsolete through the ever-rising incidence of resistance.